Hester Bio Standalone September 2023 Net Sales at Rs 66.43 crore, down 7.74% Y-o-Y
November 07, 2023 / 15:29 IST
Reported Standalone quarterly numbers for Hester Biosciences are:Net Sales at Rs 66.43 crore in September 2023 down 7.74% from Rs. 72.00 crore in September 2022.
Quarterly Net Profit at Rs. 6.78 crore in September 2023 down 34.44% from Rs. 10.35 crore in September 2022.
EBITDA stands at Rs. 13.22 crore in September 2023 down 26.39% from Rs. 17.96 crore in September 2022.
Hester Bio EPS has decreased to Rs. 7.97 in September 2023 from Rs. 12.16 in September 2022.
| Hester Bio shares closed at 1,700.90 on November 06, 2023 (NSE) and has given -5.16% returns over the last 6 months and -14.77% over the last 12 months. |
| Hester Biosciences | | Standalone Quarterly Results | in Rs. Cr. |
|
| Sep'23 | Jun'23 | Sep'22 | | Net Sales/Income from operations | 66.43 | 80.35 | 72.00 | | Other Operating Income | -- | -- | -- | | Total Income From Operations | 66.43 | 80.35 | 72.00 | | EXPENDITURE | | Consumption of Raw Materials | 8.43 | 8.43 | 6.86 | | Purchase of Traded Goods | 11.68 | 17.75 | 13.91 | | Increase/Decrease in Stocks | 0.26 | 8.16 | 0.85 | | Power & Fuel | -- | -- | -- | | Employees Cost | 14.66 | 14.13 | 13.04 | | Depreciation | 2.58 | 2.55 | 2.34 | | Excise Duty | -- | -- | -- | | Admin. And Selling Expenses | -- | -- | -- | | R & D Expenses | -- | -- | -- | | Provisions And Contingencies | -- | -- | -- | | Exp. Capitalised | -- | -- | -- | | Other Expenses | 19.41 | 20.51 | 21.56 | | P/L Before Other Inc. , Int., Excpt. Items & Tax | 9.42 | 8.82 | 13.45 | | Other Income | 1.22 | 0.86 | 2.18 | | P/L Before Int., Excpt. Items & Tax | 10.64 | 9.68 | 15.62 | | Interest | 1.48 | 0.94 | 1.74 | | P/L Before Exceptional Items & Tax | 9.16 | 8.73 | 13.88 | | Exceptional Items | -- | -- | -- | | P/L Before Tax | 9.16 | 8.73 | 13.88 | | Tax | 2.38 | 2.26 | 3.53 | | P/L After Tax from Ordinary Activities | 6.78 | 6.47 | 10.35 | | Prior Year Adjustments | -- | -- | -- | | Extra Ordinary Items | -- | -- | -- | | Net Profit/(Loss) For the Period | 6.78 | 6.47 | 10.35 | | Equity Share Capital | 8.51 | 8.51 | 8.51 | | Reserves Excluding Revaluation Reserves | -- | -- | -- | | Equity Dividend Rate (%) | -- | -- | -- | | EPS Before Extra Ordinary | | Basic EPS | 7.97 | 7.61 | 12.16 | | Diluted EPS | 7.97 | 7.61 | 12.16 | | EPS After Extra Ordinary | | Basic EPS | 7.97 | 7.61 | 12.16 | | Diluted EPS | 7.97 | 7.61 | 12.16 | | Public Share Holding | | No Of Shares (Crores) | -- | -- | -- | | Share Holding (%) | -- | -- | -- | | Promoters and Promoter Group Shareholding | | a) Pledged/Encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | b) Non-encumbered | | - Number of shares (Crores) | -- | -- | -- | | - Per. of shares (as a % of the total sh. of prom. and promoter group) | -- | -- | -- | | - Per. of shares (as a % of the total Share Cap. of the company) | -- | -- | -- | | Source : Dion Global Solutions Limited |
|
Discover the latest Business News, Sensex, and Nifty updates. Obtain Personal Finance insights, tax queries, and expert opinions on Moneycontrol or download the Moneycontrol App to stay updated!
